BMY
37
-6
MSI
55
-2
FTI
78
17
HOG
52
-2
ESS
54
10
UNP
39
-3
MSFT
62
9
VTR
44
6
PNR
62
-3
HBAN
62
-6
MTCH
55
-7
NDAQ
70
-3
GOOGL
56
3
ISRG
50
-4
SPG
43
-2
UHS
51
-4
NUE
62
-2
AVGO
38
-16
RRC
46
3
CCI
41
-3
BMY
37
-6
MSI
55
-2
FTI
78
17
HOG
52
-2
ESS
54
10
UNP
39
-3
MSFT
62
9
VTR
44
6
PNR
62
-3
HBAN
62
-6
MTCH
55
-7
NDAQ
70
-3
GOOGL
56
3
ISRG
50
-4
SPG
43
-2
UHS
51
-4
NUE
62
-2
AVGO
38
-16
RRC
46
3
CCI
41
-3
Financhill
Back

First Trust NASDAQ Technology Dividend Index Fund Vs. Nektar Therapeutics Industry Stock Comparison

Buy
60

TDIV
First Trust NASDAQ Technology Dividend Index Fund

Last Price:
$91.27
Seasonality Move:
0.9%
Buy
56

NKTR
Nektar Therapeutics

Last Price:
$24.15
Seasonality Move:
3.38%
Buy
60
First Trust NASDAQ Technology Dividend Index Fund (TDIV) is a Buy

Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?

  • The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $91.58. The Score for TDIV is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • TDIV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $25.01. The Score for NKTR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TDIV Stock Price Chart

What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?

  • The First Trust NASDAQ Technology Dividend Index Fund share price today is $91.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDIV is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $25.01
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.

TDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 20.44 Buy
Relative Strength Index (14 RSI): 70.92 Buy
Chaikin Money Flow: -15416 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (85.67 - 91.13) Buy
Bollinger Bands (100): (72.52 - 86.24) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.41 Buy
Relative Strength Index (14 RSI): 65.9 Buy
Chaikin Money Flow: -64604 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.5 - 25.8) Buy
Bollinger Bands (100): (7.55 - 17.95) Buy

TDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.67 Sell
20-day SMA: 89.29 Buy
50-day SMA: 83.97 Buy
200-day SMA: 79.8 Buy
8-day EMA: 58.26 Buy
20-day EMA: 30.32 Buy
50-day EMA: 13.59 Buy
200-day EMA: 3.6 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.32 Buy
20-day SMA: 19.57 Buy
50-day SMA: 14.05 Buy
200-day SMA: 14.55 Buy
8-day EMA: 15.41 Buy
20-day EMA: 7.97 Buy
50-day EMA: 3.56 Buy
200-day EMA: 0.94 Buy

First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.86 per share, and an increase next year of $0.01 per share.

First Trust NASDAQ Technology Dividend Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):